Full-Time

Manager/Sr. Manager

Posted on 4/23/2024

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

201-500 employees

Develops RNAi-based therapies for diseases

Biotechnology

Compensation Overview

$130,000 - $180,000Annually

+ Competitive salaries + Excellent benefit package

Senior

Pasadena, CA, USA + 1 more

Required Skills
Communications
Requirements
  • Bachelor's degree in life sciences or technical field
  • At least 3 years' experience of SAS programming for clinical trials for Manager; at least 5 years' experience Sr. Manager
  • Working knowledge of SAS, including complex data manipulation, data presentation and output deliver systems
  • Prior experience implementing edit checks and patient profiles on active clinical trials
  • Excellent verbal and written communication skills
Responsibilities
  • Develop, and execute edit checks and patient profile software or programs for clinical trials
  • Develop and execute data listing programs used by data managers, safety surveillance, medical or clinical operations personnel
  • Collaborate with data management to ensure appropriate data collection and reporting
  • Participate in study team meeting and support data management activities
  • Program and deliver results on time for ad-hoc data programming requests
  • Define and help implement statistical computing environment, specifically SAS server setup and work practices
  • Support statistical programming, from raw data to ADaM, of efficacy and safety evaluation
  • Interface with CRO and perform quality audits on CRO outputs; review outputs provided by CROs for accuracy and consistency with the programming specs
  • Assist in efforts to identify, develop, and implement departmental standards, applications, processes and training
  • Develop or support standard operation procedure preparation

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals specializes in developing RNAi-based therapies using their TRiM platform, which leverages various RNA chemistries for tissue-specific targeting, enabling rapid and durable knockdown of disease-causing genes. The TRiM platform also utilizes ligand-mediated delivery, offering potential advantages such as simplified manufacturing, reduced costs, and improved safety.

Company Stage

IPO

Total Funding

$899.9M

Headquarters

Pasadena, California

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

27%

2 year growth

61%